Patent · US Active

Insulin sensitisers and methods of treatment

US8455432B2 · kind B2 · utility

1Cited by
5References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 25, 2008
Grant dateJun 4, 2013
Priority date
Expiry dateMay 18, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitizers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.